First submission on 09/08/17; last submission on 12/11/17; accepted for publication on 13/11/17; published on 20/12/17 aBStraCt Case report of central giant cell lesion (CGCL) in a 32-year-old female patient, who exhibited asymptomatic increase in mandible volume and integrity of the adjacent alveolar mucosa, she was submitted to conservative treatment. The imaging exams showed radiolucent and multilocular lesion with displacement and discrete root resorption of the teeth 34 and 35. An incisional biopsy was performed and the final diagnosis of CGCL was established. The patient was submitted to biweekly applications of triamcinolone hexacetonide, showing no recurrence and exhibiting bone reintegration. Treatment of extensive lesions with intralesional corticosteroid injections has shown satisfactory effects.
introDuCtion
The central giant cell lesion (CGCL) was first described by Jaffe (1953) (1) as a "maxillary giant cell reparative granuloma". It is an intraosseous lesion, whose etiopathogenesis remains uncertain, and is considered reactive or neoplastic. It mainly affects patients in the younger age group, between 10 and 25 years, with incidence of 2:1 in the mandible when compared to the maxilla (2) (3) (4) .
The biological behavior of CGCL can vary from a non-aggressive lesion -in which there is no symptoms, slow growth, no cortical bone resorption or perforation -to an aggressive pathological process, exhibiting pain, paresthesia, rapid growth, root resorption and cortical perforation (5) . In radiographic analysis, CGCL can range from small unilocular apical lesions to large multilocular radiolucencies, involving the gnathic bones (4) . Histopathologically, CGCL is characterized by the proliferation of mononuclear mesenchymal cells in a matrix of fibrous connective tissue associated with the presence of numerous multinucleated giant cells (2, 3) . Although surgical treatment is the most common, however, in aggressive lesions it may cause large bone defects, impairment of fine structures and significant facial disfigurement (6) . Thus, intralesional injections of corticosteroids has been increasingly used (4, 6) . The objective of this study is to report a case of CGCL, emphasizing a conservative therapy.
CaSE rEPort
A 32-year-old female patient admitted in the Dental Department at the Hospital Batista Memorial with an slowgrowing increase in the region of left mandibular body volume and no painful symptoms ( Figure 1A) . Intraoral examination showed an increase in the volume with stony consistency, reduction in the depth of vestibular sulcus, discreet displacement of teeth 35 and 34 and integrity of the adjacent alveolar mucosa ( Figures 1B and 1C) . The image examination revealed multilocular osteolytic lesion, with cortical bone expansion, as well as discrete root resorption of the involved teeth (Figure 2) . The patient underwent an incisional biopsy, which revealed proliferation of mesenchymal cells associated with an exuberant population of multinucleated giant cells and hemorrhagic foci (Figure 3) . Tests for evaluating the serum levels of calcium, alkaline-phosphatase and parathyroid hormone were ordered and were within normal limits, ruling out Brown tumor of hyperparathyroidism (BTH), and the final diagnosis was CGCL. The patient underwent six intralesional applications, fortnightly, of 20 mg/ml triamcinolone hexacetonide diluted in anesthetic solution of 2% lidocaine/epinephrine 1:200.000 in a ratio of 1:1; 1 ml of the solution was infiltrated for each cm 3 of the lesion. Radiographic follow-up revealed increased radiopacity, associated with a reduction of the lesion when compared to the initial radiographs. However, there was persistence of a bone callus in the region (Figure 4) . One year after treatment completion, the patient performed osteoplasty of the mandible to improve the aesthetic and bone contouring. She has been under follow-up for five years, with no signs of recurrence.
DiSCuSSion
CGCL of maxillary bones is a group of uncommon lesions representing less than 7% of all benign tumor in this region (3) . It occurs mainly in children or young adults, and shows predilection for the female sex (6) . It affects the jaw frequently and usually does not present symptoms (3, 6) . Histopathologically, differential diagnosis with the brown tumor of hyperparathyroidism (BTH) and cherubism is performed (7) , however, the patient clinically exhibited a single lesion in the mandible and presented serum levels of parathyroid hormone, calcium and alkaline-phosphatase within the normal range. Thus, in the case reported, the hypotheses of cherubism and BTHs were ruled out.
The management of these lesions has traditionally been performed through surgical removal, which can result in bone and fine structures involvement (6) . Thus, alternative therapies are important, especially in cases where there may be impairment of vital structures and facial aesthetics (8) . The most commonly used conservative treatments are intralesional injection of corticosteroid, calcitonin, or the combination of both (4, 6) .
Another currently used treatment is denosumab, a human monoclonal antibody that has high affinity and specificity for the receptor activator of nuclear factor-kappa B ligand (RANKL). When binding to RANKL, denosumab mimics the inhibitory effect of osteoprotegerin, resulting in decreased osteoclast differentiation, which reduces the bone resorption caused by CGCL (9) . O'Connell et al. (2015) (9) and Naidu et al. (2014) (10) reported that denosumab presents a significant clinical response and can, therefore, be used as an alternative or adjuvant therapy in CGCL treatment. (11) report that intralesional corticosteroid injection is preferable to systemic administration because it reaches a higher concentration of the drug in the tissue. In addition, the corticosteroid approach is advantageous over other drug treatments, especially for children and young adults, who report no significant discomfort during treatment (12) . (12) reported the use of intralesional corticosteroid therapy fortnightly, maintaining the number of six applications previously reported, allowing a better follow-up of the increase in opacification observed in the control radiographs. Similarly, in the case reported here, intralesional injections of triamcinolone hexamethonide, a long-acting corticosteroid, were performed in a protocol of six biweekly applications and, subsequently, the radiopacity increase in the region affected by the lesion was observed radiographically.
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According to Carlos and Sedano (2002) (8) , the results obtained with the use of intralesional corticosteroids are due to the inhibition of the extracellular production of lysosomal proteases, as well as of the transcription factors of cell proliferation of osteoclast precursors, since it promotes apoptotic action in osteoclast-like cells. Thus, these three mechanisms stop the process of bone resorption, which results in bone regeneration and in the return of normal functions of the structures involved (6) .
ConCLuSion
The patient presented a positive response with the use of corticosteroid, exhibiting a rapid regression of the lesion and good bone repair. Therefore, in this case, this therapeutic method proved to be effective due to its low cost and not causing mutilations, maintaining the esthetics and function of the patient's stomatognathic system. 
